Screen & Treat
Program
A complete solution for cervical cancer diagnostics and treatment
Screen & Treat
Program
A complete solution for cervical cancer diagnostics and treatment
Impacting lives and changing
outcomes for women worldwide
Cervical cancer is the 4th most common cancer in women worldwide, with more than 300,000 women dying from it each year.
These deaths could have been easily prevented by timely screening and treatment.
Accessibility and loss to follow-up are a major challenge in reducing the high death toll.
60% of women screened in an initial visit for PAP or HPV, do not return for treatment.
Impacting lives and changing outcomes for women worldwide
Cervical cancer is the 4th most common cancer in women worldwide, with more than 300,000 women dying from it each year.
These deaths could have been easily prevented by timely screening and treatment.
Accessibility and loss to follow-up are a major challenge in reducing the high death toll.
60% of women screened in an initial visit for PAP or HPV, do not return for treatment.
A Holistic Approach to Women’s Health
At mobileODT, we recognize that a medical device system needs to be as flexible as its customers are unique.
We offer cervical cancer practitioners the convenience of having multiple needs met by a single supplier. Our comprehensive solution allows practitioners the flexibility to engage with mobileODT for all their cervical cancer needs.
mobileODT offers a full turnkey diagnostic and treatment program utilizing the EVAPro digital colposcope and theThermoGlide, for thermocoagulation treatment of precancerous lesions.
The single sitting “screen and treat” program allows us overcome the major challenge of loss to follow-up.
Want to Know More
About our Products?
Want to Know More
About our Products?
